Assessment of genetic integrity, splenic phagocytosis and cell death potential of (Z)-4-((1,5-dimethyl-3-oxo-2-phenyl-2,3dihydro-1H-pyrazol-4-yl) amino)-4-oxobut-2-enoic acid and its effect when combined with commercial chemotherapeutics
Título del documento: Assessment of genetic integrity, splenic phagocytosis and cell death potential of (Z)-4-((1,5-dimethyl-3-oxo-2-phenyl-2,3dihydro-1H-pyrazol-4-yl) amino)-4-oxobut-2-enoic acid and its effect when combined with commercial chemotherapeutics
Revista: Genetics and molecular biology
Base de datos: PERIÓDICA
Número de sistema: 000417979
ISSN: 1415-4757
Autores: 1
2
3
1
1
2
4
5
3
2
4
2
5
Instituciones: 1Universidade Federal de Mato Grosso do Sul, Centro de Estudos em Celulas Tronco, Terapia Celular, e Genetica Toxicologica, Campo Grande, Mato Grosso do Sul. Brasil
2Universidade Federal de Mato Grosso do Sul, Centro de Ciencias Biologicas e da Saude, Campo Grande, Mato Grosso do Sul. Brasil
3Universidade Federal de Mato Grosso do Sul, Programa de Pos-Graduacao em Saude e Desenvolvimento na Regiao Centro-Oeste, Campo Grande, Mato Grosso do Sul. Brasil
4Universidade Federal de Mato Grosso do Sul, Programa de Pos-Graduacao em Quimica, Campo Grande, Mato Grosso do Sul. Brasil
5Universidade Federal da Grande Dourados, Faculdade de Ciencias Exatas e Tecnologia, Dourados, Mato Grosso do Sul. Brasil
Año:
Periodo: Mar
Volumen: 41
Número: 1
Paginación: 154-166
País: Brasil
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Experimental
Resumen en inglés The increased incidence of cancer and its high treatment costs have encouraged the search for new compounds to be used in adjuvant therapies for this disease. This study discloses the synthesis of (Z)-4-((1,5-dimethyl-3-oxo2-phenyl-2,3dihydro-1H-pyrazol-4-yl) amino)-4-oxobut-2-enoic acid (IR-01) and evaluates not only the action of this compound on genetic integrity, increase in splenic phagocytosis and induction of cell death but also its effects in combination with the commercial chemotherapeutic agents doxorubicin, cisplatin and cyclophosphamide. IR-01 was designed and synthesized based on two multifunctionalyzed structural fragments: 4-aminoantipyrine, an active dipyrone metabolite, described as an antioxidant and anti-inflammatory agent; and the pharmacophore fragment 1,4-dioxo-2-butenyl, a cytotoxic agent. The results indicated that IR-01 is an effective chemoprotector because it can prevent clastogenic and/or aneugenic damage, has good potential to prevent genomic damage, can increase splenic phagocytosis and lymphocyte frequency and induces cell death. However, its use as an adjuvant in combination with chemotherapy is discouraged since IR-01 interferes in the effectiveness of the tested chemotherapeutic agents. This is a pioneer study as it demonstrates the chemopreventive effects of IR-01, which may be associated with the higher antioxidant activity of the precursor structure of 4-aminoantipyrine over the effects of the 1,4-dioxo-2-butenyl fragment
Disciplinas: Medicina,
Química,
Biología
Palabras clave: Terapéutica y rehabilitación,
Química farmacéutica,
Biología celular,
Fagocitosis esplénica,
Ensayo cometa,
Prueba de micronúcleos,
Muerte celular,
Quimioprevención
Keyword: Therapeutics and rehabilitation,
Medicinal chemistry,
Cell biology,
Splenic phagocytosis,
Comet assay,
Micronucleus test,
Cell death,
Chemoprevention
Texto completo: Texto completo (Ver PDF)